Peripheral Perfusion Index trajectory to predict 28-day mortality in sepsis patients in the ICU
Official title: Peripheral Perfusion Index Trajectory as a Predictor of 28-Day Mortality and Its Incremental Value Over SOFA and Lactate in Patients With Sepsis and Septic Shock: A Prospective Observational Cohort Study
Run by Trakya University · NCT07740304 · Data updated 2026-11-12
This study tests whether changes in a finger-based perfusion index over the first 24 hours in the ICU can predict 28-day death among adults with sepsis or septic shock.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Trakya University Academic / other |
| Locations | 2 sites (Edirne, Merkez and 1 other locations) |
| Status | Recruiting |
| Started | July 6, 2026 |
| Main results expected | August 7, 2027 |
| Study ends | October 7, 2027 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT07740304 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with sepsis or septic shock admitted to participating ICUs within 6 hours of admission.
✕Probably not a fit
Patients with conditions that preclude reliable PI measurement or those outside the 6-hour enrollment window may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study will track the peripheral perfusion index, derived from standard pulse oximetry, over the first 24 hours of ICU stay in adults with sepsis or septic shock. It aims to determine if PI trajectory adds predictive value for 28-day mortality beyond existing severity scores like SOFA. Additional bedside measures such as capillary refill time and skin mottling score will be recorded. The study does not introduce a treatment, but seeks to improve risk stratification by capturing microcirculatory perfusion dynamics. Enrollment is within 6 hours of ICU admission, and participation requires informed consent.
Why it matters
Potential benefit: If PI trajectory proves predictive, clinicians may improve early risk stratification and potentially tailor monitoring intensity for high-risk patients.
How similar studies have gone: Previous studies suggest a link between microcirculatory perfusion and outcomes, but dynamic PI trajectory as a predictor is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Diagnosis of sepsis or septic shock according to Sepsis-3 criteria (suspected or confirmed infection with an acute increase in SOFA score of 2 points or more) * Enrollment possible within the first 6 hours of intensive care unit admission * Written informed consent obtained from the patient or, when the patient lacks decision-making capacity, from a legal representative, in accordance with the approved consent procedure Exclusion Criteria: * Conditions precluding valid peripheral perfusion measurement at both measurement sites, including severe peripheral arterial disease, limb ischemia or amputation, extensive edema or burns, or local trauma at the measurement site * Intensive care unit stay of 24 hours or longer at another facility prior to admission * Decision to withdraw or limit life-sustaining treatment planned within the first 24 hours * Pregnancy * Severe Raynaud phenomenon or vasospastic disease of the extremities * Persistent tremor or agitation precluding standardized measurement * Concurrent enrollment in an interventional study
Where it's running
-
Trakya University Faculty of Medicine, Department of Internal Medicine, Division of Intensive Care Medicine
Edirne, Merkez, Turkey (Türkiye) Recruiting -
Uzunköprü State Hospital, Intensive Care Unit
Edirne, Uzunköprü, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Faruk Yildiz, Md — Trakya University
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Researchers will look at how γδ T cells behave in severely ill patients, including those with sepsis, to see how their metabolism and function change.
-
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Help ICU Patients Maintain Muscle Strength
This trial tests whether adding daily 60-minute thigh electrical muscle stimulation to standard ICU care is safe and easy for adults with sepsis or critical illness to see if it slows ICU-acquired muscle weakness.
-
Monocyte HLA-DR monitoring to detect immune weakness in severe intra-abdominal infections at risk for fungal invasion
This will test whether measuring monocyte HLA-DR can reveal innate immune weakness in adult ICU patients with severe intra‑abdominal infections who are at risk for invasive Candida.
-
Hyperinflammation and High Ferritin in Critically Ill Patients
This study looks at critically ill patients with signs of high inflammation to see how their condition develops over time.
-
Investigating the gut microbiome's role in sepsis and brain function in critically ill patients
This study is trying to see how changes in gut bacteria from antibiotic use affect brain function and recovery in critically ill patients with severe infections or sepsis.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.